How Trump’s tariffs could rock Aussie markets
Trump’s tariff threats are shaking markets, tech stocks are feeling the squeeze, and Aussie stocks could get caught in the crossfire.
Stockhead
ASX January Health Winners
The ASX 200 Health Care Index rose in January but Morgans healthcare analyst Iain Wilkie notes February faces volatility with Trump’s tariffs playbook looming large.
African gold’s new Rumble in the Jungle
Guinean gold explorer Predictive Discovery emerged as ASX’s hot M&A prospect after mining giants Lundin and Zijin backed a $69.2m placement.
Copper find makes AusQuest January’s star explorer
AusQuest was the star player with a potentially huge copper discovery in Peru, but gold stocks dominated the ASX resources Top 50 in January.
More Stories
Newmont in Prodigy’s corner for NT gold
Newmont’s hunger for gold is driving exploration in the Tanami and Prodigy Gold is benefitting from two JVs with the mining giant.
EBR girds for US approval for leadless ‘ticker kicker’
EBR Systems is super confident the US medical gatekeeper will approve Wise, the world’s first wireless pacemaker device.
Stocks, crypto up; Pilbara seals $560m lithium deal
ASX rebounds after Trump delays tariffs, crypto jumps, gold eyes US$3k, and Pilbara seals $560m Latin Resources deal.
Tech quarterlies: ZipCo targets US expansion
Ovanti reported a milestone quarter with former Zip Co US CFO Simon Keast appointed as its new CEO and mandate to launch BNPL offering in US.
ASX rebounds as Trump delays tariffs
ASX bounces back on Trump’s tariff delay, tech stocks shine, but Seek’s $42m deal crashes and Xref tanks 22pc.
Wellnex secures TGA approval
Wellnex obtains market authorisation with the Therapeutic Goods Administration for Liquid Paracetamol plus Caffeine Soft Gel.
Takeover whispers add lift to cashed-up PDI
Gold hunter PDI climbs on $69.2m placement amid reports of the company’s large M&A appeal.
Bio-Gene joins US in germ warfare
Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ticks and bed bugs.
Quarterlies: AI, semiconductors power tech gains
Tech small caps enjoyed strong interest in the December quarter as they pivoted to AI and semiconductor technology.
Emyria shares gain on PTSD trial news
Psychedelic drug developer Emyria says the use of MDMA (Molly, or Esstacy) has a lasting effect for post-traumatic stress disorder sufferers
Original URL: https://www.themercury.com.au/business/stockhead